All Stories

  1. Inhibitory Effects of Dabigatran on Airway Inflammation Induced by Lipopolysaccharide in Mice
  2. Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus
  3. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
  4. TNF-α Decreased Corticosteroid Responsiveness in Mice Models of Airway Inflammation Induced by Double Strand RNA and/or Tobacco Smoke Exposure
  5. The Involvement of Src in Airway Inflammation Induced by Repeated Exposure to Lipopolysaccharide in Mice
  6. In VitroandIn VivoEfficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, onAspergillus fumigatusInfection
  7. N 1 -Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice
  8. RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation
  9. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice
  10. In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice
  11. In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection
  12. Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
  13. The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice
  14. LPS causes corticosteroid insensitive airway inflammation via activation of PI3Kδ.
  15. Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma
  16. In Vivo Biomarker Analysis of Intranasally Dosed PC945, a Novel Antifungal Agent, in Aspergillus Fumigatus Infection in Immunocompromised Mice
  17. Corticosteroid sensitivity in intractable respiratory disease

  18. Correction: Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers
  19. Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers
  20. Toll-like Receptor 3 Stimulation Causes Corticosteroid-Refractory Airway Neutrophilia and Hyperresponsiveness in Mice
  21. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo
  22. Effects Of RV1088, A Narrow Spectrum Kinase Inhibitor, On Airway Inflammation And Hyperresponsiveness In Tobacco-Smoke Exposed Mice
  23. Superior Effects Of Combination Of PI3Kgamma And Delta; Inhibitors To Each Inhibitor Alone On Airway Inflammation In Tobacco-Smoke Exposed Mice
  24. Effects Of RV568, A Narrow Spectrum Kinase Inhibitor, On Airway Inflammation And Hyperresponsiveness In Tobacco-Smoke Exposed Mice
  25. Targeting Phosphoinositide-3-Kinase-δ with Theophylline Reverses Corticosteroid Insensitivity in Chronic Obstructive Pulmonary Disease
  26. Involvement Of P38MAPK Gamma On Corticosteroid Refractory Airway Inflammation Induced By Tobacco Smoke In Mice
  27. Synthesis of Water-Soluble Polyamine Derivatives Effective as N-Methyl-D-aspartate Receptor Antagonists
  28. Thrombin-stimulated proliferation is mediated by endothelin-1 in cultured rat gingival fibroblasts
  29. Neuroprotection by Tosyl-Polyamine Derivatives through the Inhibition of Ionotropic Glutamate Receptors
  30. Synthesis of a Novel Water-Soluble Cleft-Type Cyclophane as an N-Methyl-D-aspartate Receptor Antagonist
  31. Synthesis of Two Novel Water-soluble Cleft-Type Cyclophanes Effective as N-Methyl-D-aspartate Receptor Antagonist
  32. Differential effects of linear and cyclic polyamines on NMDA receptor activities
  33. Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors
  34. Cyclophane and acyclic cyclophane: Novel channel blockers of N-methyl-d-aspartate receptor
  35. Effects of Dexamethasone and Aminophylline on Survival of Jurkat and HL-60 Cells
  36. Inhibition of angiotensin II- and endothelin-1-stimulated proliferation by selective MEK inhibitor in cultured rabbit gingival fibroblasts+
  37. Design and Synthesis of a Novel Water-Soluble NMDA Receptor Antagonist with a 1,4,7,10-Tetraazacyclododecane Group
  38. Monoamines directly inhibit N-methyl-d-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner
  39. Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis
  40. Pharmacological properties of angiotensin II receptors in cultured rabbit gingival fibroblasts
  41. Proliferative effects of angiotensin II and endothelin-1 on guinea pig gingival fibroblast cells in culture
  42. Effects of endothelin-1 and nitric oxide on proliferation of cultured guinea pig bronchial smooth muscle cells
  43. Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats
  44. Evidence for the AT1 Subtype of the Angiotensin II Receptor in the Rat Submandibular Gland.
  45. Activation of Protein Kinase C Induces Internalization of the GABAC Receptors Expressed in Xenopus Oocytes
  46. Antigen-induced elevation of immunoreactive endothelin-1 (ET-1) levels in ovalbumin-sensitized guinea pig airway tissue
  47. Consensus phosphorylation sites of human GABAC/GABAρ receptors are not critical for inhibition by protein kinase C activation
  48. β-Funaltrexamine Discriminates between Two Subtypes of μ2-Opioid Receptors in Electrically Stimulated Longitudinal Muscle of Guinea Pig Ileum
  49. Synergistic actions of pentobarbital and dihydropyridine Ca2+antagonists on guinea pig isolated thoracic aorta
  50. GABA θ1 receptor: inhibition by protein kinase C activators
  51. Effects of organic and inorganic Ca2+-antagonists on acetylcholine-induced contraction in molluscan (Mytilus edulis) smooth muscle
  52. Immunochemical and immunohistochemical determination of ubiquitin in molluscan (Mytilus edulis) smooth muscle
  53. Inhibitory action of McN-A-343 on acetylcholine-induced contraction in molluscan smooth muscle
  54. Possible site of action of 2-methylserotonin in inducing relaxation of acetylcholine-induced contraction in the molluscan (Mytilus edulis) smooth muscle
  55. Effect of ageing on response to nicotine in rabbit bronchial preparation
  56. Organic Ca2+-antagonist-resistant response to FMRF-NH2 on the molluscan smooth muscle
  57. Effects of chronic nicotine treatment on nicotinic receptors in the rabbit urinary bladder
  58. Effect of ageing on nicotine-induced contraction of guinea-pig bronchial preparation
  59. Substance P-containing nerves mediate nicotine-induced contractions of rabbit bronchial smooth muscle
  60. Pharmacological action of nicotine in the isolated urinary bladder from rabbit: Special reference to the chronic nicotine treatment
  61. Characterization of nicotine-induced contraction in the canine bronchus
  62. Noncholinergic contractile response to nicotine in the guinea pig isolated tracheal smooth muscle
  63. (±)-1-[[2-(3,4-Dimethoxphenyl) ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride (bevantolol, NC-1400) as a β1-selective adrenoceptor blocker with α1-adrenoceptor blocking activity
  64. Actions of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)amino]propoxy)benzeneacetamide (KF4317) and labetalol on α- and β-adrenoceptors
  65. Mechanism of action of nicotine on crab-eating monkey isolated bronchial smooth muscle
  66. Possible involvement of substance P immunoreactive nerves in the mediation of nicotine-induced contractile responses in isolated guinea pig bronchus
  67. Tetrodotoxin-resistant response to nicotine in rabbit bronchial preparation
  68. Nicotinic stimulant, DMPP(1,1-dimethyl-4-phenylpiperazinium iodide) on the isolated bronchial smooth muscle preparation of guinea-pig
  69. Action of nicotine on guinea-pig isolated bronchial smooth muscle preparation
  70. A possible site of action of nicotine in the bronchial smooth muscle preparation of guinea-pig
  71. A receptor reserve of the alpha-inhibitory receptor for alpha-adrenoceptor stimulants in the taenia caecum of guinea pig.